How have OREXQ shares performed in 2024?

Orexigen Therapeutics' stock was trading at $0.0053 at the start of the year. Since then, OREXQ shares have increased by 0.0% and is now trading at $0.0053. View the best growth stocks for 2024 here .

How do I buy shares of Orexigen Therapeutics?

Shares of OREXQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:OREXQ

Orexigen Therapeutics (OREXQ) Stock Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free OREXQ Stock Alerts

$0.0053

+0.00 (+35.90%)

(As of 05/31/2019)

Compare

Today's Range: $0.0027
▼
$0.0053
50-Day Range: $0.0053
▼
$0.0053
52-Week Range: $0.00
▼
$0.16

Volume: 60,300 shs
Average Volume: 80,439 shs
Market Capitalization: $100,101.10

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Orexigen Therapeutics alerts:

Ad DTI

Special FREE offer on stock hotsheets

These sheets tell you the exact day you should consider buying a stock… And the exact day you should consider selling it… All based on TEN YEARS of historic data and trends. For example, like January 6th through the 12th with Apple… It’s gone up every single year for the last decade. Or like May 26th through June 11th with LULU… Again - it’s gone up every single year for the last decade. Then there’s July 1st through the 21st with Walmart… What happened to WMT?

Click here and I’ll show you

About Orexigen Therapeutics

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products primarily in the United States, Europe, and South Korea. It offers Contrave for the treatment of obesity. The company also offers Contrave under the Mysimba brand name. Orexigen Therapeutics, Inc. was founded in 2002 and is headquartered in La Jolla, California. On March 12, 2018, Orexigen Therapeutics, Inc., filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

OREXQ Stock Price History

30 days | 90 days | 365 days | Advanced Chart

OREXQ Stock News Headlines

February 2, 2024 | investing.com

Axsome Therapeutics Inc (AXSM)

November 4, 2023 | morningstar.com

Heron Therapeutics Inc HRTX

April 19, 2024 | Darwin (Ad)

Your Next Portfolio Star: Revealing 2024's Top Stock Pick

We're thrilled to offer you an exclusive look at the #1 Buy & Hold Stock of 2024. This isn't just any report. It's the culmination of rigorous analysis, expert insights, and cutting-edge financial strategies, distilled into a compelling narrative that charts the course of what we believe to be the year's most promising investment. (**By clicking the link you are subscribing to The Wealth Creation Investing Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)

February 19, 2023 | thestreet.com

Orexigen Therapeutics (OREX) Stock Climbs on $60 Million Investment

January 18, 2022 | thestreet.com

Orexigen Therapeutics (OREX) Stock Declines After Halting Heart Benefit Tests

November 5, 2021 | markets.businessinsider.com

Wall Street Crime and Punishment: Martin Shkreli, The Self-Destructive Pharma Bro

See More Headlines

Receive OREXQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orexigen Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Pharmaceutical Preparations
Sub-Industry: N/A
Current Symbol: OTCMKTS:OREXQ
CUSIP: N/A
CIK: 1382911
Web: www.orexigen.com
Phone: 858-875-8600
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $33.71 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 18,887,000
Free Float: N/A
Market Cap: $100,101.10
Optionable: Not Optionable
Beta: 4.98

Beginner's Guide to Pot Stock Investing

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

Mr. Thomas P. Lynch (Age 52)
Consultant

Key Competitors

View All Competitors

OREXQ Stock Analysis - Frequently Asked Questions

How have OREXQ shares performed in 2024?: Orexigen Therapeutics' stock was trading at $0.0053 at the start of the year. Since then, OREXQ shares have increased by 0.0% and is now trading at $0.0053.
View the best growth stocks for 2024 here.
How do I buy shares of Orexigen Therapeutics?: Shares of OREXQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:OREXQ) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial